News

Allogene Therapeutics Showcases Commitment Through Conferences

Allogene Therapeutics Showcases Commitment Through Conferences

Allogene Therapeutics to Participate in Investor Conferences

Allogene Therapeutics, Inc. (NASDAQ: ALLO), is a pioneering biotechnology company dedicated to developing cutting-edge allogeneic CAR T (AlloCAR T™) products targeting cancer and autoimmune diseases. Recently, the company has announced its involvement in several prominent investor conferences scheduled for the upcoming weeks. These conferences provide critical platforms for Allogene to engage with investors and share its innovative approaches in the biotechnology field.

Upcoming Conferences Overview

Allogene will be featuring its advancements and key insights at four significant conferences:

TD Cowen’s 6th Annual Oncology Innovation Summit

This summit is set to take place on Tuesday, offering vital discussions centered on oncology innovations. The event is crucial for understanding the future of cancer therapy and features leading experts in the field. Allogene will share its vision and insights at 9:30 AM PT/12:30 PM ET.

Jefferies Global Healthcare Conference

Next up is the Jefferies Global Healthcare Conference, happening on June 4. Allogene’s participation is scheduled for the afternoon session at 1:55 PM PT/4:55 PM ET, where they will present their latest developments and strategies aimed at enhancing patient care through innovative therapies.

Goldman Sachs 46th Annual Global Healthcare Conference

This prestigious event will occur on June 10, demonstrating a robust agenda filled with discussions and insights from various healthcare leaders. Allogene will present at 5:00 AM PT/8:00 AM ET, discussing its commitment to providing breakthrough cell therapies.

Oppenheimer Innovators in I&I Summit

Finally, the company will make its mark at the Oppenheimer Innovators in I&I Summit on June 25, presenting at 9:45 AM PT/12:45 PM ET. This summit highlights innovation in immunology and inflammation, areas of significant focus for Allogene.

Webcasting and Accessibility

For those unable to attend in person, Allogene Therapeutics will provide webcasts of the presentations, which will be accessible on their official website. Following each live session, recordings will be available for approximately 30 days, ensuring that all interested parties can catch up on the insights shared by Allogene’s leadership.

Company Overview: Allogene Therapeutics

Based in South San Francisco, Allogene is at the forefront of developing innovative allogeneic chimeric antigen receptor (CAR) T cell therapies for treating cancer and autoimmune diseases. With a team possessing substantial experience in cell therapy, the company is creating a pipeline of off-the-shelf CAR T cell product candidates. Their goal is to make cell therapy available on demand and more accessible to patients, addressing the critical need for timely treatments.

Contact Information

For media and investor inquiries, Christine Cassiano serves as the company’s Executive Vice President, Chief Corporate Affairs & Brand Strategy Officer. Those interested in further information can reach out via email at Christine.Cassiano@allogene.com.

Frequently Asked Questions

What is Allogene Therapeutics known for?

Allogene Therapeutics specializes in developing allogeneic CAR T cell therapies aimed at treating cancer and autoimmune diseases.

How does Allogene's participation in conferences benefit its stakeholders?

Participation in conferences allows Allogene to share insights about its innovative therapies and engage directly with investors, enhancing transparency and collaboration.

Where can I find the presentations from these conferences?

Webcasts of Allogene’s presentations will be available on their website for approximately 30 days following each event.

What is CAR T cell therapy?

CAR T cell therapy involves modifying a patient’s T cells to better recognize and attack cancer cells, providing a personalized approach to treatment.

How can I stay updated on Allogene’s developments?

You can follow Allogene Therapeutics on their official website as well as on social media platforms like X and LinkedIn for the latest updates.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Orthopedic Expert Highlighting Midwest Pain Access Gaps

Updated Category News Views 5

Over in the vast sprawl of rolling plains and prairie winds, folks in the Upper Midwest are grappling with an ironic reality. As technological advancements blaze trails, people suffering from vertebrogenic pain are finding themselves up against a wall of limited access to specialized care. We’ve got Dr. James T. Brunz, the man of the hour, one of only about 15 Intracept...

Continue Reading
Citrine Finalizes Sale of Illinois Senior Living Asset

Updated Category News Views 6

Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...

Continue Reading
MSP360 Unveils Free Proxmox Backup: A Game Changer?

Updated Category News Views 8

Backing Up: New Paths for Proxmox Users Ever get that feeling of uncovering something truly worth its weight in gold? That's what MSP360 just dropped on us, with their new backup solution for Proxmox that won’t cost you a dime upfront. They're calling it the Community Edition, and it’s not only free, but it comes with all the bells and whistles for protecting those...

Continue Reading
Alcott HR's Sales Strategy Gets a Boost with New Hire

Updated Category News Views 9

Alcott HR Ramps Up Sales Firepower Now here's something fresh from the world of human resources outsourcing—Alcott HR has grabbed a new ace for their sales team. Eldin Radoncic is the name you'll want to remember, folks, because he's diving headfirst into the Director of Sales seat at this IRS Certified and ESAC Accredited player based out in good old Farmingdale, New...

Continue Reading
Lumicell Expands LumiSystem in Breast Cancer Surgery

Updated Category News Views 6

Innovation in Breast Cancer Surgery: A Real-World Game Changer? You’ve got your flashlight guiding a scared child through the dark, and in the healthcare world, Lumicell is promising to do just that for surgeons navigating the tricky maze of breast cancer surgery. Their LumiSystem is making waves in breast-conserving surgery—new kid on the block with a real chance at...

Continue Reading
WellLink Advisory Board Eyes Future of Healthcare Innovation

Updated Category News Views 3

Strategic Collaboration for Healthcare Evolution Ready to shake things up in healthcare, WellLink is setting the stage with its brand new Advisory Board. This move isn’t just about having fancy titles sitting around a conference table — it's about grabbing onto the future with both hands and figuring out just what the heck the healthcare industry needs next....

Continue Reading
BMAP Expands: Bridging Borders in Legal Advocacy

Updated Category News Views 5

Breaking Down BMAP's Unique Approach Just when you thought you've seen it all, along comes LMU Loyola Law School swinging the doors wide open with their Binational Migrant Advocacy Project, or as we’re affectionately calling it, BMAP. It's a mouthful, sure, but ain't it something? This project isn't just another feather in academia's cap—it's a relentless counterpunch...

Continue Reading
TGI Fridays Unveils New 3 For All Menu Options

Updated Category News Views 8

Hedging Bets on New Dining Strategies Oh, the restaurant battlefield—where one day you're the toast of the town, and the next, you're hustling to keep those seats filled. TGI Fridays, a name as synonymous with casual eats as long as I’ve been in this game, is rolling the dice with a new offering dubbed '3 For All.' Doesn't sound like your average meal deal either....

Continue Reading
Mutare Sharpens Security for Webex Calls with Precision

Updated Category News Views 5

Control Dialed In: Tailored Call Screening Kicking things up a notch, Mutare is redefining call security by fine-tuning their Voice Security for Webex Calling. Imagine this—custom rules now let organizations shape a security policy down to the very last detail, ensuring unwanted calls don’t slip through the cracks. Wave goodbye to the broad-strokes approach. Precision...

Continue Reading
Paula's Choice Elevates Skincare Game with New Campaign

Updated Category News Views 6

Strategy Meets Skincare: Paula's Choice in the Spotlight Catch this: Paula's Choice just dropped a moisturizer, but it ain't just lotion. No, the Pro-Collagen Peptide Plumping Intensive Moisturizer is here with a punch. And they've got Hannah Waddingham, of 'Ted Lasso' fame, fronting a campaign that screams confidence. Now, that's a way to announce your move at the...

Continue Reading

Top 5 Most Recently Viewed Articles

Nine Minds' AlgaPSA Appliance: Game-Changer for MSPs

Updated Category News Views 8

Breaking the Mold in Professional Services Automation Well, here's a twist that's lighting a fire under the seats of managed service providers (MSPs): Nine Minds just rolled out the AlgaPSA appliance, and it's stirring up quite the buzz. This ain't your standard, run-of-the-mill PSA (professional services automation) setup. Nope, we're talking a self-hosted shindig here....

Continue Reading
Cushman & Wakefield Welcomes Tom McDonnell to Leadership Team

Updated Category News Views 269

Cushman & Wakefield Welcomes Tom McDonnell to Leadership Team Cushman & Wakefield has recently appointed Tom McDonnell as the Executive Regional Director for the Northwest Region. This strategic move is aimed at bolstering the company's presence and operations in an essential market that includes several key states. Leadership Responsibilities In his new role, McDonnell...

Continue Reading
Societe Generale's EUR 1 Billion Bond Stabilization Process

Updated Category News Views 193

Societe Generale's New Bond and Stabilization Efforts Societe Generale (OTC: SCGLY) has taken a significant step by announcing the stabilization of its newly issued EUR 1 billion bond. This bond, which features a 3.75% coupon, is scheduled to mature on July 15, 2031. The stabilization period, which began recently, is planned to extend until no later than February 14,...

Continue Reading
WISeSat.Space Takes Innovation to New Heights with Blockchain

Updated Category News Views 129

WISeSat.Space Takes Innovation to New Heights WISeKey International Holding, recognized for its cutting-edge advancements in cybersecurity and IoT solutions, has recently put its focus on WISeSat.Space. This subsidiary is pioneering the integration of space technology with blockchain and cryptocurrency. Their recent feature on Swiss Radio Television has spotlighted this...

Continue Reading
Arts of Imagination Foundation Celebrates Iconic Art Acquisition

Updated Category News Views 318

Iconic Art Acquisition by the Arts of Imagination Foundation The Arts of Imagination Foundation (AOIF) has proudly announced an exceptional addition to its collection: the original cover art for the beloved book Charlotte's Web, created by the talented illustrator Garth Williams. This noteworthy acquisition not only honors a widely cherished children’s classic but also...

Continue Reading